Catherine Ramsey
Stock Analyst at Baird
(3.89)
# 550
Out of 4,784 analysts
44
Total ratings
51.52%
Success rate
10.91%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Upgrades: Outperform | $396 → $407 | $362.16 | +12.38% | 8 | Mar 26, 2025 | |
| ILMN Illumina | Maintains: Neutral | $127 → $90 | $80.00 | +12.50% | 5 | Mar 5, 2025 | |
| NTRA Natera | Maintains: Outperform | $183 → $188 | $143.94 | +30.61% | 6 | Feb 28, 2025 | |
| CSTL Castle Biosciences | Maintains: Outperform | $36 → $37 | $19.94 | +85.56% | 8 | Feb 28, 2025 | |
| TWST Twist Bioscience | Maintains: Outperform | $48 → $54 | $40.36 | +33.80% | 6 | Feb 4, 2025 | |
| RVTY Revvity | Maintains: Outperform | $136 → $138 | $105.62 | +30.66% | 3 | Nov 5, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $695 → $665 | $500.16 | +32.96% | 2 | Nov 1, 2022 | |
| A Agilent Technologies | Maintains: Outperform | $155 → $160 | $116.69 | +37.12% | 5 | Aug 17, 2022 | |
| EXAS Exact Sciences | Maintains: Outperform | $90 → $75 | $43.66 | +71.78% | 1 | Aug 3, 2022 |
Waters
Mar 26, 2025
Upgrades: Outperform
Price Target: $396 → $407
Current: $362.16
Upside: +12.38%
Illumina
Mar 5, 2025
Maintains: Neutral
Price Target: $127 → $90
Current: $80.00
Upside: +12.50%
Natera
Feb 28, 2025
Maintains: Outperform
Price Target: $183 → $188
Current: $143.94
Upside: +30.61%
Castle Biosciences
Feb 28, 2025
Maintains: Outperform
Price Target: $36 → $37
Current: $19.94
Upside: +85.56%
Twist Bioscience
Feb 4, 2025
Maintains: Outperform
Price Target: $48 → $54
Current: $40.36
Upside: +33.80%
Revvity
Nov 5, 2024
Maintains: Outperform
Price Target: $136 → $138
Current: $105.62
Upside: +30.66%
Thermo Fisher Scientific
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $500.16
Upside: +32.96%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $116.69
Upside: +37.12%
Exact Sciences
Aug 3, 2022
Maintains: Outperform
Price Target: $90 → $75
Current: $43.66
Upside: +71.78%